Sc
Scorpion
Boston MAFounded 2020120 employees
Private CapbiotechPrivateOncology
Platform: Precision Onc
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pemizasiran | SCO-6284 | Phase 1/2 | 2 | MDM2 | DravetFSGS | ||
| Nirasertib | SCO-4950 | Phase 2/3 | 2 | CD19 | GISTMCC | ||
| SCO-5362 | SCO-5362 | NDA/BLA | 2 | USP1 | CRCMDD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)